image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 7.29
6.11 %
$ 9.29 M
Market Cap
-0.02
P/E
INCOME STATEMENT
6.51 M REVENUE
-89.46%
12.6 M OPERATING INCOME
129.48%
23.9 M NET INCOME
133.37%
EFFICIENCY
Earnings Waterfall RedHill Biopharma Ltd.
image
Revenue 6.51 M
Cost Of Revenue 3.46 M
Gross Profit 3.05 M
Operating Expenses -9.56 M
Operating Income 12.6 M
Other Expenses -11.3 M
Net Income 23.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010
REVENUE
Revenue 6.5 61.8 85.8 64.4 6.3 8.4 4.0 0.1 3 K 7.0 12 K 16 K 23 K 0
GROSS PROFIT
Cost Of Revenue 3.5 33.3 49.4 36.9 2.3 2.8 2.1 30.5 22.0 1.1 0 0 0 0
Gross Profit 3.1 28.5 36.4 27.5 4.0 5.5 1.9 (30.4) (22.0) 6.0 12 K 16 K 23 K 0
OPERATING INCOME
Operating Expenses (9.6) 71.3 117.5 91.2 47.2 44.9 53.9 30.6 22.0 16.6 10.8 9.1 7.9 1.7
Selling, General and Administrative Expenses 31.0 64.0 88.0 74.7 29.8 20.0 20.0 5.4 4.1 4.0 2.7 2.6 2.5 0.5
Research and Development Expenses 3.5 7.3 29.5 16.5 17.4 24.9 33.0 25.2 17.8 12.7 8.1 6.5 5.4 0.7
Operating Income 12.6 (42.8) (81.1) (63.7) (43.2) (39.3) (52.0) (30.5) (22.0) (10.6) (10.8) (9.0) (7.9) (1.7)
PRE-TAX INCOME
Interest Income Expense 0.4 41.3 16.6 12.8 0.4 0.2 77 K 0.4 0.2 0.4 14 K 1.5 65 K 0.9
Total Other Income 11.3 (28.8) (16.6) (12.5) 0.9 0.5 6.4 1.2 0.8 64 K 0.1 (1.3) (7.6) (0.8)
Pre-Tax Income 24.0 (71.7) (97.7) (76.2) (42.3) (38.8) (45.5) (29.4) (21.1) (10.7) (10.6) (10.3) (15.5) (2.5)
NET INCOME
Tax Provision 0 (12.4) 16.6 12.8 1.3 0.7 6.3 1.3 0.9 0.2 0.1 1.3 7.6 0.9
Net Income 23.9 (59.2) (114.3) (89.0) (43.6) (38.8) (45.5) (29.4) (21.1) (10.7) (10.6) (10.3) (15.5) (2.5)
EPS 3.69 38.3 98.3 97.8 58.8 68 104 95 76.1 49.5 68.2 80 129 19.4